SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Clouseau who wrote (1180)1/13/2000 8:56:00 PM
From: Russian Bear  Read Replies (1) | Respond to of 2001
 
I haven't read the Yahoo! posts in question, but it seems a silly explanation. Adcon-P, etc., and Intergel are not chemically similar, only functionally, and so drawing approval parallels is unwarranted, it seems to me.

In fact, by that twisted logic, it would have been a positive for GLIA, had Intergel been recommended for approval! Clearly, a nonsense conclusion.

RB



To: Clouseau who wrote (1180)1/14/2000 9:07:00 AM
From: LLCF  Respond to of 2001
 
<OK - Yahoo posters opine that GLIA will face similar difficulty in future approvals. Guess that is the reason, eh? . >

Blind Squirrel disagrees:

Message 12568066

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News